EQNR vs HLX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Equinor exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is currently trading at a severe premium to its deterministic value. The current price of $37.94 is more than double the Graham Number ($18.78) and nearly triple the growth-based intrinsic value ($13.58). This valuation gap is compounded by sharply negative growth metrics, including a 27.3% YoY decline in earnings and a 0/100 bearish technical trend. While the balance sheet is healthier than the sector average, the combination of valuation overshoot and deteriorating fundamentals suggests significant downside risk.
HLX presents a stark disconnect between market price and fundamental value, evidenced by a Piotroski F-Score of 4/9 (Stable) and a Graham Number of $4.91, which is roughly half the current trading price. While the balance sheet is healthy with low debt and strong liquidity, the company is suffering from a catastrophic earnings collapse (-550% YoY EPS growth) and negative operating margins. The current P/E of 99.30 is unsustainable, and the stock's valuation relies entirely on optimistic forward estimates (Forward P/E 17.81) that are not yet supported by realized growth. With a technical trend score of 10/100 and bearish insider activity, the current price appears to be driven by momentum rather than intrinsic value.
Compare Another Pair
Related Comparisons
EQNR vs HLX: Head-to-Head Comparison
This page compares Equinor ASA (EQNR) and Helix Energy Solutions Group, Inc. (HLX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.